Cancer, diabetes, survival and glycemic control: a large multisite analysis
- PMID: 36788982
- PMCID: PMC9912249
- DOI: 10.2144/fsoa-2022-0018
Cancer, diabetes, survival and glycemic control: a large multisite analysis
Abstract
Aim: To determine overall survival (OS) and glycemic control in patients with cancer and diabetes.
Materials & methods: Patients of our institution with breast, colon, lung, pancreas and prostate cancer were retrospectively reviewed. OS was compared between matched patients with and without diabetes, and changes in glucose value over time were assessed.
Results: For 3934 patients each with and without diabetes, adjusted analysis showed no difference in OS according to diabetes status (hazard ratio: 1.07; 95% CI: 0.96-1.20). Mean glucose values decreased over time in patients with and without diabetes (p = 0.01).
Conclusion: In this large study of patients with five common cancers, the co-occurrence of diabetes did not affect OS. Cancer did not adversely affect glucose levels.
Keywords: cancer; oncology; outcomes research.
Plain language summary
The aim of this study was to evaluate survival and glucose control in patients with cancer and diabetes at three separate geographic locations in a single health system. From an institutional cancer registry, we identified patients with breast, colon, lung, pancreas and prostate cancers. Patients with and without diabetes were matched by age, sex, cancer type, staging, geographic location and year of cancer diagnosis. In this study, the co-occurrence of diabetes did not affect overall survival. Cancer did not adversely affect glucose levels.
© 2023 Mayo Foundation for Medical Education & Research.
Figures
References
-
- Centers for Disease Control and Prevention. National Diabetes Statistics Report 2020 (2020). http://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-stati...
-
- Centers for Disease Control and Prevention. United States Cancer Statistics: prevalence (2021). https://gis.cdc.gov/Cancer/USCS/#/Prevalence/
-
- Centers for Disease Control and Prevention. Changes Over Time: All Types of Cancer (2021). https://gis.cdc.gov/Cancer/USCS/#/Trends/
-
- Karlin NJ, Dueck AC, Cook CB. Cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice. Endocr. Pract. 18(6), 898–905 (2012). - PubMed
-
• Shows that diabetes was common, glycemic control often was suboptimal and survival varied by cancer type.
LinkOut - more resources
Full Text Sources